Literature DB >> 8518026

Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites.

J Kirk1, S Houlbrook, N S Stuart, I J Stratford, A L Harris, J Carmichael.   

Abstract

In this study we describe the effects of tamoxifen, toremifene and their 4-hydroxy and N-desmethyl metabolites on the toxicity of a range of drugs to human breast and lung cancer and to Chinese hamster ovary cell lines, determined using a tetrazolium-based semi-automated colorimetric assay. Vinblastine resistance was completely abolished in an mdr1-transfected lung cancer cell line (S1/1.1), indicating that P-glycoprotein-mediated multidrug resistance can be fully reversed by anti-oestrogens. A substantial (14- to 39-fold) enhancement of vinblastine toxicity to highly multidrug-resistant (MCF-7Adr) cells expressing P-glycoprotein was also observed in the presence of tamoxifen, toremifene and their metabolites, while m-amsacrine, cisplatin and melphalan toxicity was unaffected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518026     DOI: 10.1016/s0959-8049(05)80306-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer.

Authors:  L R Wiseman; K L Goa
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

2.  Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours.

Authors:  T W Beer; D C Rowlands; J Crocker
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

3.  P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

Authors:  Jacqueline V Chapman; Valérie Gouazé-Andersson; Ramin Karimi; Maria C Messner; Myles C Cabot
Journal:  Exp Cell Res       Date:  2011-03-21       Impact factor: 3.905

4.  Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.

Authors:  J J Zhang; T J Jacob; M A Valverde; S P Hardy; G M Mintenig; F V Sepúlveda; D R Gill; S C Hyde; A E Trezise; C F Higgins
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Authors:  Cheol-Hee Choi
Journal:  Cancer Cell Int       Date:  2005-10-04       Impact factor: 5.722

6.  Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.

Authors:  J Kirk; J Carmichael; I J Stratford; A L Harris
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

7.  Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

Authors:  R Callaghan; C F Higgins
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.